GLOBAL COUNCIL ON ALZHEIMER'S DISEASE

1 total filings · 0 classes · Active since Aug 2014

Watch Brand
Download PDF Free with sign-in. Joins our weekly trademark roundup.

GLOBAL COUNCIL ON ALZHEIMER'S DISEASE holds 1 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 16 (Paper & Printed Goods) with 1 filings. The WikiTrademarks Expansion Score is 5/100, low — the brand is focused on defending its existing categories rather than expanding.

USPTO data refreshed November 16, 2026

Protect or track "GLOBAL COUNCIL ON ALZHEIMER'S DISEASE"

Watch this name and we'll alert you when anyone files a similar mark.

Informational only, not a legal opinion. Consult a trademark attorney before filing or enforcing.

Own this brand? Claim the profile to add your logo, story, and website.

Sign in to claim

How is GLOBAL COUNCIL ON ALZHEIMER'S DISEASE filing trademarks, and where is the portfolio expanding?

Filing Velocity (24 Months)

Dec 2024 Nov 2026

Activity Timeline

No activity recorded yet.

Recent Filings

Serial No. Mark Filing Date Status Classes Owner
86362061 GLOBAL COUNCIL ON ALZHEIMER'S DISEASE Aug 09, 2014 Pending 016 Paper & Printed Goods 035 Advertising & Business 041 Education & Entertainment 042 Science & Technology Otsuka America Pharmaceutical, Inc.
See how ChatGPT talks about GLOBAL COUNCIL ON ALZHEIMER'S DISEASE Beta

Weekly visibility reports showing how ChatGPT mentions GLOBAL COUNCIL ON ALZHEIMER'S DISEASE, where you rank in the answer, the sentiment of the mention, and which sources ChatGPT cites.

Join waitlist →

FAQ: GLOBAL COUNCIL ON ALZHEIMER'S DISEASE trademark portfolio

What trademarks does GLOBAL COUNCIL ON ALZHEIMER'S DISEASE hold?

GLOBAL COUNCIL ON ALZHEIMER'S DISEASE holds 1 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 16 (Paper & Printed Goods), Class 35 (Advertising & Business), Class 41 (Education & Entertainment). The most recent filings are registered to Otsuka America Pharmaceutical, Inc..

How many trademarks does GLOBAL COUNCIL ON ALZHEIMER'S DISEASE have at the USPTO?

WikiTrademarks tracks 1 USPTO trademark filings attributed to GLOBAL COUNCIL ON ALZHEIMER'S DISEASE. The brand has been actively filing since August 2014. The count updates daily as new filings are indexed from the USPTO bulk data feed.

In which NICE classes does GLOBAL COUNCIL ON ALZHEIMER'S DISEASE file most often?

GLOBAL COUNCIL ON ALZHEIMER'S DISEASE's most active class is NICE Class 16 (Paper & Printed Goods), with 1 filings. The full distribution across all 0 classes is shown in the Nice Class Distribution panel on this page.

Who owns the GLOBAL COUNCIL ON ALZHEIMER'S DISEASE trademark?

The most recent filings under the GLOBAL COUNCIL ON ALZHEIMER'S DISEASE mark are registered to Otsuka America Pharmaceutical, Inc.. Trademark ownership can shift through assignments — see the Ownership & Assignment History section on this page for the full chain of title.

Is GLOBAL COUNCIL ON ALZHEIMER'S DISEASE expanding into new categories?

The current WikiTrademarks Expansion Score for GLOBAL COUNCIL ON ALZHEIMER'S DISEASE is 5 out of 100, which is low — the brand is focused on defending its existing categories rather than expanding. The score combines NICE class breadth, filing velocity, and the rate of cross-class movement from the brand's filing history.

How can I track new GLOBAL COUNCIL ON ALZHEIMER'S DISEASE trademark filings?

Click the Watch Brand button at the top of this page to add GLOBAL COUNCIL ON ALZHEIMER'S DISEASE to your Watchlist. New filings show up on your WikiTrademarks dashboard within 24 to 48 hours of being public, alongside any class expansions, status changes, or assignment events.

More on this portfolio: Compare GLOBAL COUNCIL ON ALZHEIMER'S DISEASE to another owner · Browse all NICE classes · Most valuable brands

Community notes

0 notes
Sign in to add a note

Share what you know about GLOBAL COUNCIL ON ALZHEIMER'S DISEASE and help the next person researching it.

No notes yet. Be the first to add what you know about GLOBAL COUNCIL ON ALZHEIMER'S DISEASE.